Loading…
Loading…
NexPoint Residential Trust (NXRT) remains a Hold as leverage increases, guidance declines, and dividend coverage thins despite a widening NAV discount. Q2 2026 results showed modest revenue growth but declining AFFO and same-store NOI, driven by higher interest expenses and softer revenues. NXRT trades at a 47% discount to NAV, but this discount appears structural due to persistent leverage and refinancing risks.
NexPoint Residential Trust (NYSE: NXRT - Get Free Report) and Morguard North American Residential Real Estate Investment Trust (OTCMKTS:MNARF - Get Free Report) are both real estate companies, but which is the better investment? We will contrast the two companies based on the strength of their earnings, valuation, profitability, institutional ownership, analyst recommendations, dividends and risk.
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
EDRY, OPBK, SUPN, MSBI and NXRT have been added to the Zacks Rank #1 (Strong Buy) List on August 7th, 2026.
BCAL, SUPN and NXRT made it to the Zacks Rank #1 (Strong Buy) value stocks list on August 7th, 2026.
NXRT, QUAD and MSBI made it to the Zacks Rank #1 (Strong Buy) income stocks list on August 7th, 2026.
NexPoint Residential Trust Inc. (NXRT) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.
NexPoint Residential Trust NYSE: NXRT lowered its full-year 2026 core funds from operations guidance after higher projected interest expense and softer-than-expected revenue in several markets, despite management pointing to improving leasing trends and lower operating-cost growth.